Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials.
Elisabeth Eckersberger;
Julia Finkelstein;
Helen Sadri;
Markus Margreiter;
Samir S Taneja;
Herbert Lepor;
Bob Djavan;
(2009)
Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials.
Reviews in urology, 11 (3).
pp. 127-133.
ISSN 1523-6161
https://material-uat.leaf.cosector.com/id/eprint/2130245
The advent of prostate-specific antigen (PSA) testing in the early 1980s revolutionized the diagnosis of prostate cancer. As a result of PSA testing, there has been a surge in the number of prostate cancer diagnoses. This review examines the results of 2 recent landmark trials that studied the effect of screening on prostate cancer mortality: the European Randomized Study of Screening for Prostate Cancer (ERSPC) and the US-based Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
| Item Type | Article |
|---|
Explore Further
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777060 (OA Location)
- 19918338 (PubMed)